SUNGKYUNKWAN UNIVERSITY SCHOOL OF MEDICINE

On November 8, the Ministry of Science and ICT announced that professor Joo Sang Lee was selected for the ‘2022 National R&D Excellence 100’. The Ministry of Science and ICT has been selecting excellent national R&D achievements every year since 2006 to enhance public understanding and interest in the role of science and technology and to inspire pride in scientists and engineers.

Prof. Joo Sang Lee was recognized for his achievement in developing a new medical platform, SELECT, that can dramatically improve existing personalized medicine. Recently, personalized medicine for cancer patients, which selects and treats the most suitable treatment based on big data, is on the rise. Prof. Lee’s research team can provide patients with the most efficient treatment by predicting which anticancer drugs will be effective based on the patient’s genetic data before cancer treatment, through the personalized media platform SELECT. The researchers analyzed data from about 50 clinical trials involving 5,000 patients, including various cancer types, targeted treatments, and immunotherapy conducted at cancer centers around the world, and were able to predict the response rate and survival rate of patients for about 70% of anticancer drugs. It has been shown that there is a possibility of presenting an effective treatment for more than twice as many patients as compared to conventional cancer personalized treatment. In the future, it is expected to offer hope to cancer patients and medical staff through verification through clinical trials and the improvement of predictive power through artificial intelligence models.